10 Cytokinetics regulatory affairs leaders
VP, Head of Regulatory Affairs Europe, Vice President, Regulatory Affairs and Compliance, North America and Senior Director, Head of Regulatory Labeling are titles these Cytokinetics regulatory affairs leaders hold today. A reader can learn how regulatory affairs leaders work at Cytokinetics from people who have held the role.
Professionals to explore
Ann Paradise-Jasniewski
LinkedInExperience: Director, CCDS & Labeling · Cytokinetics
Ann Paradise-Jasniewski has been Director, CCDS & Labeling at Cytokinetics since January 2025, based in Kenosha, Wisconsin. They were Associate Director, CCDS & Labeling (2018–2025) and Senior Manager, CCDS & Labeling (2016–2018) at Astellas Pharma, and Senior Manager, Global Labeling at Takeda (2014–2016).
Beth Lage
LinkedInExperience: Senior Director, Head of Regulatory Labeling · Cytokinetics
Beth Lage has been Senior Director, Head of Regulatory Labeling at Cytokinetics since March 2024, based in Antioch, Illinois. They were Director Global Regulatory Affairs at Astellas Pharma US (2018–2024), Director, Regulatory Affairs, Global Labeling at BioMarin (2016–2018) and Associate Director Regulatory Affairs at Baxter Healthcare (2013–2016).
Christine Murray, MS, RAC
LinkedInExperience: SVP Regulatory and Quality · Cytokinetics
Christine Murray has been SVP Regulatory and Quality at Cytokinetics since April 2023, based in the San Francisco Bay Area. They were Vice President Regulatory Affairs at Ultragenyx (2017–2018), Vice President, Global Regulatory Affairs at Raptor Pharmaceuticals (acquired by Horizon Pharma) (2015–2017) and Vice President, Regulatory Affairs and Quality Assurance at Achaogen (2011–2015).
Khalid Farrag
LinkedInExperience: Director, Regulatory Affairs Europe · Cytokinetics
Khalid Farrag has been Director, Regulatory Affairs Europe at Cytokinetics since June 2026, based in Zug, Switzerland. They were Senior Director, Regulatory Affairs Lead at Medicines for Malaria Venture (2023–2025), Director, Sr. Global Regulatory Lead - Immunology at CSL (2021–2023) and Head of Regulatory Science and Policy - Director at CSL Vifor (2019–2021).
Klara Dalmay
LinkedInExperience: Senior Director Commercial Regulatory Affairs - Business Operations - Europe · Cytokinetics
Klara Dalmay has been Senior Director Commercial Regulatory Affairs - Business Operations - Europe at Cytokinetics since February 2026, in Kanton Zug, Switzerland. They were Director, Regional Regulatory Strategy, EUCCA at Moderna (2024–2026) and Director Regulatory Affairs, EMEA at PTC Therapeutics, Inc. (2017–2023).
Michael Epstein, MS
LinkedInExperience: Head of Regulatory Operations and Submission Management · Cytokinetics
Michael Epstein has been Head of Regulatory Operations and Submission Management at Cytokinetics since June 2024, based in New Hope, Pennsylvania. They were Vice President, Regulatory Operations and Submission Management at Reata Pharmaceuticals, Inc. in 2023 and Executive Director, Regulatory Operations at Acadia Pharmaceuticals (2018–2023).
Neila Benabadji
LinkedInExperience: VP, Head of Regulatory Affairs Europe · Cytokinetics
Neila Benabadji has been VP, Head of Regulatory Affairs Europe at Cytokinetics since April 2024, based in Basel, Switzerland. They were Associate Vice President, Global Regulatory Affairs - Head of RA Development Strategy & RA EMEA (2022–2024) and Senior Director, Head Regulatory Affairs EMEA (2021–2022) at Reata Pharmaceuticals, Inc.
Rachel E. Melman
LinkedInExperience: Vice President, Regulatory Affairs and Compliance, North America · Cytokinetics
Rachel E. Melman has been Vice President, Regulatory Affairs and Compliance, North America at Cytokinetics since August 2026, based in San Francisco, California. At Cytokinetics they were also Executive Director, Regulatory Affairs (2024–2026), Senior Director, Regulatory Affairs (2020–2024) and Director, Regulatory Affairs (2017–2020), and their profile describes early and late phase development work as well as commercial compliance.
Stefanie Töpperwien
LinkedInExperience: Senior Director Regulatory Affairs · Cytokinetics
Stefanie Töpperwien has been Senior Director Regulatory Affairs at Cytokinetics since February 2025, based in Zug, Switzerland. They were Director, Regulatory Affairs at Pfizer (2024–2025), Director, Regulatory Affairs at Seagen (2022–2023) and Director Regulatory Strategy at bluebird bio (2021).
Tiffany Wan
LinkedInExperience: Senior Director, Regulatory Affairs · Cytokinetics
Tiffany Wan has been Senior Director, Regulatory Affairs at Cytokinetics since October 2025, based in San Francisco, California. They were Senior Director, Regulatory Affairs at ArriVent Biopharma (2025), Executive Director, Regulatory Affairs (2023–2024) and Senior Director, Regulatory Affairs (2022–2023) at Sana Biotechnology, Inc., and Senior Director, Regulatory Affairs at Nkarta, Inc. (2020–2022).
Choose the right perspective
Match the person's regulatory area and region, whether US or European strategy, labeling or regulatory operations, to the question you are working on. Weigh how long someone has held a regulatory role at the company against the range of regulatory roles they held elsewhere.
Questions to take into the conversation
- 01How is regulatory work divided between the US and European teams, and where do the hand-offs get hard?
- 02What did you change first when you took over your part of the regulatory function, and why?
- 03Which decisions does a regulatory leader own outright, and which are shared with clinical, quality or commercial colleagues?
Reaching Cytokinetics regulatory affairs leaders
How can I contact one of these Cytokinetics regulatory affairs leaders?
Pick one of the 10 people on this page and choose "Book a paid call", or describe your project to find others. You offer a fee for a 15-minute call or a written answer, Instant Expert finds the person's work email and sends the invitation, and they decide whether to accept. The list covers 1 company: Cytokinetics, based on profile data retrieved on October 26, 2026. Being listed here doesn't mean someone has agreed to take calls.
How much does it cost to reach Cytokinetics regulatory affairs leaders?
You choose the offer, starting at $5 per person. The offer is what the person receives, and Instant Expert's fee is added on top, so a $100 offer costs you $125. The fee is 20% of what you pay. You're charged only when the person books the call or sends the answer.
What if they don't reply?
You pay nothing. Instant Expert sends follow-up reminders, and if the person hasn't booked or answered within 7 days, the request expires and any hold on your card is released. You can invite several of the 10 people on this list at once and cap your total spend, so you pay only for the ones who accept.
Can an AI agent ask one of these Cytokinetics regulatory affairs leaders a question?
Yes. An agent with a USDC wallet on Base can ask one question without an Instant Expert account. It names the person, for example by the LinkedIn URL on this page, and pays per ask over x402 (HTTP 402). The person answers in writing or by voice note, and if nobody answers within 7 days, the payment goes back to the wallet automatically. Claude and ChatGPT can do the same through the Instant Expert connector: setup is at /docs/mcp for Claude and /docs/chatgpt for ChatGPT. x402 docs
About this directory
This is a professional research starting point based on business profile data retrieved on . Titles and companies reflect that source snapshot; roles marked former had ended by then. Check the linked profiles for current details. Inclusion does not imply Instant Expert membership or availability.